Joseph S Zakrzewski - Net Worth and Insider Trading

Joseph S Zakrzewski Net Worth

The estimated net worth of Joseph S Zakrzewski is at least $16 Million dollars as of 2024-11-13. Joseph S Zakrzewski is the Director of Insulet Corp and owns about 27,849 shares of Insulet Corp (PODD) stock worth over $8 Million. Joseph S Zakrzewski is the Director of Acceleron Pharma Inc and owns about 34,499 shares of Acceleron Pharma Inc (XLRN) stock worth over $6 Million. Joseph S Zakrzewski is also the Director of Cyteir Therapeutics Inc and owns about 362,340 shares of Cyteir Therapeutics Inc (CYTT) stock worth over $1 Million. Besides these, Joseph S Zakrzewski also holds AN2 Therapeutics Inc (ANTX) , Amarin Corp PLC (AMRN) , Sangamo Therapeutics Inc (SGMO) . Details can be seen in Joseph S Zakrzewski's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph S Zakrzewski has not made any transactions after 2024-01-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Joseph S Zakrzewski

To

Joseph S Zakrzewski Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph S Zakrzewski owns 6 companies in total, including Amarin Corp PLC (AMRN) , Sangamo Therapeutics Inc (SGMO) , and Acceleron Pharma Inc (XLRN) among others .

Click here to see the complete history of Joseph S Zakrzewski’s form 4 insider trades.

Insider Ownership Summary of Joseph S Zakrzewski

Ticker Comapny Transaction Date Type of Owner
AMRN Amarin Corp PLC 2021-12-15 director & Chief Executive Officer
SGMO Sangamo Therapeutics Inc 2020-03-17 director
XLRN Acceleron Pharma Inc 2021-04-05 director
LIMIT LIMIT 2017-03-02 director
LIMIT LIMIT 2022-12-07 director
LIMIT LIMIT 2024-01-18 director

Joseph S Zakrzewski Latest Holdings Summary

Joseph S Zakrzewski currently owns a total of 6 stocks. Among these stocks, Joseph S Zakrzewski owns 27,849 shares of Insulet Corp (PODD) as of March 2, 2017, with a value of $8 Million and a weighting of 48.98%. Joseph S Zakrzewski owns 34,499 shares of Acceleron Pharma Inc (XLRN) as of April 5, 2021, with a value of $6 Million and a weighting of 39.42%. Joseph S Zakrzewski also owns 362,340 shares of Cyteir Therapeutics Inc (CYTT) as of December 7, 2022, with a value of $1 Million and a weighting of 6.97%. The other 3 stocks AN2 Therapeutics Inc (ANTX) , Amarin Corp PLC (AMRN) , Sangamo Therapeutics Inc (SGMO) have a combined weighting of 4.63% among all his current holdings.

Latest Holdings of Joseph S Zakrzewski

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PODD Insulet Corp 2017-03-02 27,849 275.10 7,661,260
XLRN Acceleron Pharma Inc 2021-04-05 34,499 178.75 6,166,696
CYTT Cyteir Therapeutics Inc 2022-12-07 362,340 3.01 1,090,643
ANTX AN2 Therapeutics Inc 2024-01-18 504,079 1.06 534,324
AMRN Amarin Corp PLC 2021-12-15 196,547 0.55 108,573
SGMO Sangamo Therapeutics Inc 2020-03-17 30,000 2.71 81,150

Holding Weightings of Joseph S Zakrzewski


Joseph S Zakrzewski Form 4 Trading Tracker

According to the SEC Form 4 filings, Joseph S Zakrzewski has made a total of 0 transactions in Insulet Corp (PODD) over the past 5 years. The most-recent trade in Insulet Corp is the sale of 40,000 shares on March 2, 2017, which brought Joseph S Zakrzewski around $2 Million.

According to the SEC Form 4 filings, Joseph S Zakrzewski has made a total of 1 transactions in Acceleron Pharma Inc (XLRN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Acceleron Pharma Inc is the sale of 10,000 shares on April 5, 2021, which brought Joseph S Zakrzewski around $1 Million.

According to the SEC Form 4 filings, Joseph S Zakrzewski has made a total of 6 transactions in Cyteir Therapeutics Inc (CYTT) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Cyteir Therapeutics Inc is the acquisition of 21,202 shares on December 7, 2022, which cost Joseph S Zakrzewski around $27,563.

More details on Joseph S Zakrzewski's insider transactions can be found in the Insider Trading History of Joseph S Zakrzewski table.

Insider Trading History of Joseph S Zakrzewski

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joseph S Zakrzewski Trading Performance

GuruFocus tracks the stock performance after each of Joseph S Zakrzewski's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph S Zakrzewski is 17.35%. GuruFocus also compares Joseph S Zakrzewski's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph S Zakrzewski within 3 months outperforms 7 times out of 12 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joseph S Zakrzewski's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joseph S Zakrzewski

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
8 out of 12 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.29 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 4.64 LIMIT LIMIT LIMIT LIMIT LIMIT

Joseph S Zakrzewski Ownership Network

Ownership Network List of Joseph S Zakrzewski

No Data

Ownership Network Relation of Joseph S Zakrzewski

Insider Network Chart

Joseph S Zakrzewski Owned Company Details

What does Amarin Corp PLC do?

Who are the key executives at Amarin Corp PLC?

Joseph S Zakrzewski is the director & Chief Executive Officer of Amarin Corp PLC. Other key executives at Amarin Corp PLC include EVP & President US Aaron Berg , director & See Remarks Patrick Holt , and Chief Scientific Officer Steven B Ketchum .

Amarin Corp PLC (AMRN) Insider Trades Summary

Over the past 18 months, Joseph S Zakrzewski made no insider transaction in Amarin Corp PLC (AMRN). Other recent insider transactions involving Amarin Corp PLC (AMRN) include a net purchase of 314,426 shares made by Patrick Holt , a net purchase of 160,000 shares made by Aaron Berg , and a net sale of 34,131 shares made by Steven B Ketchum .

In summary, during the past 3 months, insiders sold 0 shares of Amarin Corp PLC (AMRN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 34,131 shares of Amarin Corp PLC (AMRN) were sold and 474,426 shares were bought by its insiders, resulting in a net purchase of 440,295 shares.

Amarin Corp PLC (AMRN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Amarin Corp PLC Insider Transactions

No Available Data

Joseph S Zakrzewski Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph S Zakrzewski. You might contact Joseph S Zakrzewski via mailing address: 509 Waterview Place, New Hope Pa 18938.